Pharmacovigilance Market Trend will witness a sustainable 10.3% growth

1
Pharmacovigilance Market share to exceed 8bn by
2024 Fractovia.org
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights of Pharmacovigilance Market

• Pharmacovigilance Market will generate a revenue
  of more than USD 8 billion by 2024.
• Pharmacovigilance market is trending toward a
  remarkable growth path, owing to the presence of
  global organizations such as WHO, that undertake
  the responsibility to monitor the safety and
  effects of licensed drugs.
• Stringent government rules pertaining to the
  approval of drugs and their safety will also
  influence pharmacovigilance industry share
  considerably.
• Contract outsourcing segment accounted for more
  than 50 of market share in 2015, and is
  anticipated to collect a revenue of more than USD
  4.8 billion by 2024.
• Based on the clinical trial trends,
  pharmacovigilance industry is mainly divided into
  phase I, preclinical, phase II, phase III, and
  phase IV. Phase IV clinical trial was worth USD
  2.4 billion in 2015 and will record an annual
  growth rate of 10.9 over the coming years of
  2016 to 2024, primarily driven by rising concerns
  among the public regarding the safety and adverse
  effects of drug events.

3
Continued

• Europe pharmacovigilance industry was worth USD
  793 million in 2015 and will collect a revenue of
  USD 1.8 billion by 2024, with an annual growth
  rate of 9.9 over the coming seven years.
• Asia Pacific pharmacovigilance market collected a
  revenue of USD 835 million in 2015 and will
  surpass a revenue collection of USD 2.4 billion
  by 2024, owing to the implementation of stringent
  health care norms along with the presence of a
  huge patient base across this region.
• U.S. pharmacovigilance industry share will
  register a CAGR of 10.7 over the period of 2016
  to 2024.
• Many of the market players are willing to sign
  strategic partnerships with contract research
  organizations to provide customized services.
• The key participants in pharmacovigilance market
  are Accenture, Covance, Boehringer Ingelheim,
  PAREXEL, Bristol-Myers Squibb, United BioSource
  Corporation, Cognizant Technology Solutions
  Corporation, Quintiles, and ICON plc.

4
U.S. Pharmacovigilance Market size, by service
provider, 2012- 2024 (USD Million)

5

Browse Full Market Research Report of
Pharmacovigilance Market _at_ http//bit.ly/2pd5Kas
Request for a Sample of this Research
report _at_ https//www.fractovia.org/request-sample
/388
6
Table of Contents
Chapter 1. Methodology and Scope 1.1.
Research Methodology 1.1.1. Initial data
exploration 1.1.2. Statistical modeling and
forecast 1.1.3. Industry insights and
validation 1.1.4. Research scope and
assumptions 1.2. Data
Sources 1.2.1. Primary Sources 1.2.2.
Secondary Sources Chapter 2. Executive
Summary 2.1. Pharmacovigilance industry 3600
synopsis, 2012 - 2024 2.1.1. Business
trends 2.1.2. End user trends 2.1.3.
Regional trends Chapter 3. Pharmacovigilance
Industry Insights 3.1. Industry
segmentation 3.2. Industry size and forecast,
2012 - 2024
7
Continued
3.3. Industry impact forces 3.3.1. Growth
drivers 3.3.1.1. Increase in adoption rate
of outsourcing services 3.3.1.2.
Increasing consumption of drugs 3.3.1.3.
Rise in adverse drug reactions (ADR) and drug
toxicity 3.3.2. Industry pitfalls
challenges 3.3.2.1. Dearth of availability
of skilled personnel 3.3.2.2. High risk
associated with data security 3.4. Growth
potential analysis 3.4.1. New business
models 3.5. Porters analysis 3.6. Regulatory
Landscape 3.7. Pharmacovigilance Reporting
system 3.8. Company market share analysis,
2015 3.8.1. Strategy dashboard 3.9. PESTEL
analysis
8
Stay In Touch Website https//www.fractovia.org
Social Media